TIP30 interacts with an estrogen receptor alpha-interacting coactivator CIA and regulates c-myc transcription
about
Identification of common differentially expressed genes in urinary bladder cancerCrystal structure of CC3 (TIP30): implications for its role as a tumor suppressorNuclear receptor coactivators: the key to unlock chromatinNCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinomaDirect cooperation between androgen receptor and E2F1 reveals a common regulation mechanism for androgen-responsive genes in prostate cells.Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expressionOncogenic protein MTBP interacts with MYC to promote tumorigenesisA novel TIP30 protein complex regulates EGF receptor signaling and endocytic degradation.Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcome.CC3/TIP30 regulates metabolic adaptation of tumor cells to glucose limitationTip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors.Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor.Global gene expression profiling of brown to white adipose tissue transformation in sheep reveals novel transcriptional components linked to adipose remodelingAn LXR-NCOA5 gene regulatory complex directs inflammatory crosstalk-dependent repression of macrophage cholesterol efflux.Mediator subunits MED1 and MED24 cooperatively contribute to pubertal mammary gland development and growth of breast carcinoma cells.TIP30 loss enhances cytoplasmic and nuclear EGFR signaling and promotes lung adenocarcinogenesis in miceHigh serum HTATIP2/TIP30 level in serous ovarian cancer as prognostic or diagnostic markerDecreased TIP30 expression promotes tumor metastasis in lung cancer.Association of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infection.Factors that retard remyelination in multiple sclerosis with a focus on TIP30: a novel therapeutic target.Glucose intolerance and hepatocellular carcinoma: recent findings for old diseases.Role of CCN5 (WNT1 inducible signaling pathway protein 2) in pancreatic islets.A single non-synonymous NCOA5 variation in type 2 diabetic patients with hepatocellular carcinoma impairs the function of NCOA5 in cell cycle regulation.TIP30 is associated with progression and metastasis of prostate cancer.Anterior tongue cancer with no history of tobacco and alcohol use may be a distinct molecular and clinical entity.Integrated genomic profiling identifies loss of chromosome 11p impacting transcriptomic activity in aggressive pituitary PRL tumors.NCOA5 promotes proliferation, migration and invasion of colorectal cancer cells via activation of PI3K/AKT pathway.TIP30 inhibits oligodendrocyte precursor cell differentiation via cytoplasmic sequestration of Olig1.A novel tumor suppressor gene NCOA5 is correlated with progression in papillary thyroid carcinoma.Reduction of Tat-interacting Protein 30 Expression Could be a Prognostic Marker in Bladder Urothelial Cancer.
P2860
Q21135503-336C8A2F-952D-4971-ADD6-D7E329DA8D4BQ28236516-92C6F766-F064-4819-B67A-42FC3E2773D8Q28266740-EEE216AA-3667-4585-BDDE-F19EE0D3AC16Q28586911-067A8CE0-A819-4C77-B473-59D10DA7C8A6Q33636324-EF9BE463-F3E3-488D-BEA1-D1DAB61C5893Q33720151-02EFDE43-0E10-458B-86BA-8D30EF54C8FCQ33838577-B8AF4FC5-C926-4545-B932-9EB0D6E02A82Q34160054-F8B05B8B-F270-4671-813F-3B75F486D0A4Q34166257-B9C45919-AE7A-469A-BB67-3D80205C9048Q34619824-6B132B22-548F-4676-B2EC-F528F70A2F86Q34783850-9FA3871B-A8AF-4946-B9E6-66C5923FBD7BQ35193155-C9BBB24D-A14C-4B0E-870D-DC8308195E3EQ35532336-EEE97183-25CB-49E5-8ADB-7F28A3612C09Q35590401-3FA0377B-5909-4770-A181-B5DB7BD6A508Q35867938-E5447986-93FD-46B2-9F2D-13CDC54C306AQ36285249-5D4BBB11-BFFF-4546-BE17-293042D1BB87Q36964290-E0F09255-7383-47DA-94E6-09068A26D686Q37164265-98F110D5-5F78-4910-A915-41360151171AQ37321012-F148AE8C-0A60-454A-A651-974B319387CAQ37617353-AC3D16F0-058A-4BE1-AEEB-A92ED6CDD8A3Q37722922-BCED01D7-0D34-431D-8F3C-EB0637FE055EQ38730332-6674D38C-5E00-4C45-A9F0-28F8D4FA58DEQ38991357-ACBA5BC2-8AE0-4007-8441-2C23AA4545B9Q39975033-D2F0165C-DCD1-4BBE-B229-BBEBB03F85CCQ42219876-B5D6B77C-A419-4F24-AC4E-88B39BF45CDFQ44588158-0E69EF3C-3A68-4971-99E1-A0ECF2A5EA76Q47123866-4C746DBC-C93B-40D2-B145-66F2C0F7AD7DQ48403962-79794294-386E-4D4B-BE9A-94CF9914E64BQ49387480-84F82668-69EC-4E07-84D1-02AF6EF12726Q49510268-F206ED25-CC9C-4DE7-B76A-6DB4F40BD3BF
P2860
TIP30 interacts with an estrogen receptor alpha-interacting coactivator CIA and regulates c-myc transcription
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
TIP30 interacts with an estrog ...... regulates c-myc transcription
@ast
TIP30 interacts with an estrog ...... regulates c-myc transcription
@en
TIP30 interacts with an estrog ...... regulates c-myc transcription
@nl
type
label
TIP30 interacts with an estrog ...... regulates c-myc transcription
@ast
TIP30 interacts with an estrog ...... regulates c-myc transcription
@en
TIP30 interacts with an estrog ...... regulates c-myc transcription
@nl
prefLabel
TIP30 interacts with an estrog ...... regulates c-myc transcription
@ast
TIP30 interacts with an estrog ...... regulates c-myc transcription
@en
TIP30 interacts with an estrog ...... regulates c-myc transcription
@nl
P2093
P2860
P3181
P356
P1476
TIP30 interacts with an estrog ...... regulates c-myc transcription
@en
P2093
Chao Jiang
Kristy Bruck
Mitsuhiro Ito
Robert G Roeder
Valerie Piening
P2860
P304
P3181
P356
10.1074/JBC.M401809200
P407
P577
2004-06-25T00:00:00Z